Overall, the incidence of colorectal cancer has decreased over the decades, largely in part due to the use of screening ...

Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted ...

A recent prospective cross-sectional study in Thailand demonstrates that multitarget stool DNA testing is highly sensitive and specific for detecting colorectal cancer (CRC) among Thai individuals.

Exact Sciences (NASDAQ:EXAS) has received approval from the U.S. Food and Drug Administration (FDA) for its non-invasive multitarget stool DNA test to detect colorectal cancer in adults ages 45 and ...

CRANSTON, R.I. (WPRI) — The Cranston Fire Department has become the first in Rhode Island to test new cancer-screening technology. EsoGuard is a non-invasive DNA test, introduced by Lucid Diagnostics, ...

India, March 23 -- Advances in cancer research are improving how doctors diagnose and monitor diseases. One emerging tool is ...

Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, enabling timely medical guidance and informed decision-making.

Women are often juggling work, family, and social roles, leaving little time for their own health. The modern genetic and ...